Literature Study and Suggestions on the Development Situation of Online Drugstores in China
- VernacularTitle:我国网上药店发展现状的文献研究及建议
- Author:
Jinwei ZHANG
1
;
Shuchen HU
1
;
Zhengze XU
1
;
Kailai LIU
1
;
Longcheng WU
1
;
Caijun YANG
1
Author Information
1. School of Pharmacy，Xi’an Jiaotong University，Xi’an 710061，China
- Publication Type:Journal Article
- Keywords:
Online drugstores;
Regulatory policies;
Situation;
Literature analysis;
Suggestion
- From:
China Pharmacy
2021;32(14):1678-1684
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To p rovide policy suggestions for the development and supervision of online drugstores in China. METHODS：By literature review ，the relevant literatures and policy documents about the development of online drugstores were searched，screened and sorted out to summarize the development process of China ’s internet drug trading mode and policy ，analyze the development status of China ’s online drugstores ；on the basis of the development experience of some developed countries ，the suggestions were put forward for China ’s relevant policies. RESULTS & CONCLUSIONS ：China’s medical e-commerce started relatively late ，and the policies related to online drug trading were basically released during last 20 years. The number of online drugstores showed a growing trend. The online drugstores were geographically allocated widely but unevenly. They sold many varieties，and policies on selling prescription medicines were gradually liberalized. These online drugstores provided diverse payment and delivery choices ，but their pharmaceutical service needed to be improved. The development models of online drugstores in the United Kingdom ，the United States and Germany could be referred. According to the current situation of online drugstores in China ， combined with the development mode and operation strategy in foreign countries ，it is suggested to improve relevant laws and regulations，and strengthen legal support ；strengthen the government supervision to ensure drug safety ；use the industrial power to standardize medicine operation behavior ；set up the third part trading platform to promote medical insurance payment.
